Models of Dementia Assessment and Diagnosis: Indicative Cost Review

NHS England, September 2015

This report identifies and reviews in detail three models of dementia assessment and diagnosis currently being used in dementia care in the NHS in England. Through semi-structured interviews with each unit it presents indicative costs for each model, benefits for patients and carers, key messages and considerations about developing the service, giving insight into how a local Clinical Commissioning Group (CCG) might approach a review of their local service with an aim to making improvements.

Click here to view the full report.

Dementia: GPs say patchy services fail patients

BBC News, 6 July 2015

Doctors have raised fresh concerns about the level of support people with dementia and their carers get from the NHS and social services in the UK.

And the Royal College of GPs says until the situation improves, doctors will have to weigh up whether there is any advantage in early diagnosis…

Click here to view the full story.

Classification, assessment, prevalence, and effect of personality disorder

The Lancet, 21-27 February 2015

Personality disorders are common and ubiquitous in all medical settings, so every medical practitioner will encounter them frequently. People with personality disorder have problems in interpersonal relationships but often attribute them wrongly to others. No clear threshold exists between types and degrees of personality dysfunction and its pathology is best classified by a single dimension, ranging from normal personality at one extreme through to severe personality disorder at the other. The description of personality disorders has been complicated over the years by undue adherence to overlapping and unvalidated categories that represent specific characteristics rather than the core components of personality disorder. Many people with personality disorder remain undetected in clinical practice and might be given treatments that are ineffective or harmful as a result. Comorbidity with other mental disorders is common, and the presence of personality disorder often has a negative effect on course and treatment outcome. Personality disorder is also associated with premature mortality and suicide, and needs to be identified more often in clinical practice than it is at present.

Click here to view the full text.  You will need to login with your Athens password to view this article.

All Lancashire Care staff are eligble to register for an Athens password.  Please click here to register for an Athens password.

US panel proposes new name and diagnostic criteria for chronic fatigue syndrome

BMJ, 10 February 2015

The condition known as myalgic encephalitis (ME) or chronic fatigue syndrome (CFS) is a serious, chronic multisystem disease that can cause significant impairment and disability, an expert panel convened by the US Institute of Medicine has concluded in a new report…

Click here to read the full text article.  You will need to login with your Athens password to view this article. 

All Lancashire Care staff are eligble to registerfor an Athens password.  Please click here to register for an Athens password.

Don’t let care home residents slip through the dementia net – Alistair Burns

NHS England, 18 December 2014

Alistair Burns, NHS England’s National Clinical Director, has teamed up with two Dementia Ambassadors, Dan Harwood and Paul Twomey, to give their views on improving diagnosis in care homes – why, and how to do it.

Click here to view the full text article.

New perspectives and approaches to understanding dementia and stigma

International Longevity Centre, 28 October 2014

This new compendium of essays examines the social stigma which surrounds dementia, highlighting that stigma is impending early diagnosis, care and research into the disease.

The report, New perspectives and approaches to understanding dementia and stigma, published by the International Longevity Centre UK (ILC-UK) in collaboration with the MRC, Alzheimer’s Research UK, Alzheimer’s Society and supported by the drug company Pfizer, shines a light on the impact the fear around dementia has on those living with the condition, their families and carers, which prevents the research community capturing a full picture of the disease.

Click here for further information and to download a copy of the report.